Genoskin is a Contract Research Organization (CRO) transforming preclinical research with advanced ex vivo human skin and mast cell platforms. Using donated human tissue and primary human cells, Genoskin provides ready-to-use, living models that deliver human-relevant data for evaluating efficacy, absorption, toxicity, and immune responses to both topical and injectable products.
As a more predictive and ethical alternative to animal testing, Genoskin’s customizable platforms help biopharma and cosmetic companies generate high-quality, reproducible data before clinical trials. Complementing these models are advanced molecular and spatial biology capabilities—including bulk RNA sequencing, single-cell RNA sequencing, and spatial transcriptomics—that reveal treatment-induced changes at the tissue, cellular, and spatial levels.
By combining innovative human models with deep biological insights, Genoskin helps partners accelerate the development of safer, more effective therapeutics, vaccines, medical devices, and cosmetic products.